Further investigation is warranted to elucidate the role of the CCL21/CCR7 axis in the pathogenesis of Hashimoto’s thyroiditis and evaluate its therapeutic potential as a novel treatment target. This evidence concerns the gene CCR7 and Hashimoto thyroiditis.